STRUCTURE & FUNCTION OF SNAKE VENOM GLYCOPROTEINS
结构
基本信息
- 批准号:6123257
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
RVV-X (93 kDa) and RVV-V (31 kDa), the coagulation factor X and V
activating glycoproteins of Russell's Viper venom, are synthesized by
the same venom gland and are capable of activating blood coagulation
factors X and V, respectively. They both contain N-linked
oligosaccharides but are differentially glycosylated. Cobra venom
mucin is a high molecular weight, heavily glycosylated protein that is
secreted abundantly by the cobra venom gland. It contains largely
0-linked oligosaccharides with terminal cc-galactosylated Le' and Le'
antigenic determinants. Recent studies suggest that this mucin
activates human complement in an cc-galactoside residue-dependent
manner The carbohydrates released from RVV-X., RVV-V and cobra mucin
were analyzed by a combination of electrospray mass spectrometry,
collision-induced decomposition (CID), and for cobra mucin, specific
enzymatic hydrolysis. The objective was to provide broad mass
profiles and general structural features for the N-linked glycans
while more specific structural details for the cobra mucin oligomers
were sought, related to the presence of theantigenic (x-galactose
residues. Base-released oligosaccharide alditols from cobra mucins
were partitioned on Bio-Gel P 30 columns and then digested with coffee
bean (x-galactosidase. By comparing the mass profiles for the smaller
oligomers before and after enzyme treatment, combined with CID
structural analysis, it was shown that (x-galactosidase sensitivity
required the presence of a terminal hexose-hexose pair. The
combination of endo-o-galactosidase and CID wasused to probe for
internal structural features such as branching and tandem hexose
repeats. Molecular weight distributions of the intact species of the
very large oligomers are being determined by M[ALDI-TOF MS.
RVV-X (93 kDa)和RVV-V (31 kDa),凝血因子X和V
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D C GOWDA其他文献
D C GOWDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D C GOWDA', 18)}}的其他基金
PARASITE CYTOADHERENCE MECHANISM IN MATERNAL MALARIA
母体疟疾中的寄生虫细胞粘附机制
- 批准号:
6345216 - 财政年份:2000
- 资助金额:
-- - 项目类别:
PARASITE CYTOADHERENCE MECHANISM IN MATERNAL MALARIA
母体疟疾中的寄生虫细胞粘附机制
- 批准号:
6478940 - 财政年份:2000
- 资助金额:
-- - 项目类别:
PARASITE CYTOADHERENCE MECHANISM IN MATERNAL MALARIA
母体疟疾中的寄生虫细胞粘附机制
- 批准号:
6206411 - 财政年份:1999
- 资助金额:
-- - 项目类别:
相似海外基金
REU Site: University of Colorado, Engineering Smart Biomaterials
REU 站点:科罗拉多大学,工程智能生物材料
- 批准号:
2348856 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
An iPSC based xeno-free platform to assess the foreign body response against new biomaterials
基于 iPSC 的无异源平台,用于评估新生物材料的异物反应
- 批准号:
NC/Y000838/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: Developing Ultrasound-Programmable 3D-Printed Biomaterials for Spatiotemporal Control of Gene Delivery
职业:开发用于基因传递时空控制的超声波可编程 3D 打印生物材料
- 批准号:
2339254 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Antimicrobial biomaterials from bio-based feedstocks with novel feedstock supplementation strategies
采用新型原料补充策略的生物基原料制成的抗菌生物材料
- 批准号:
10063453 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Collaborative R&D
FET: Small: Simulation-guided design of heterochiral DNA nanostructures for biomaterials applications
FET:小型:用于生物材料应用的异手性 DNA 纳米结构的模拟引导设计
- 批准号:
2312215 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
CAREER: Surfactant Proteins that Stabilize Biomolecular Condensates: From Biophysics to Biomaterials for Biomanufacturing
职业:稳定生物分子缩合物的表面活性剂蛋白:从生物物理学到生物制造的生物材料
- 批准号:
2238914 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
CAREER: Modular Protein Origami to Build Genetically Programmable Biomaterials
职业:用模块化蛋白质折纸构建基因可编程生物材料
- 批准号:
2239927 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
Pathophysiology and prevention of degeneration of heterograft biomaterials due to advanced glycation end products and serum protein infiltration
由于晚期糖基化终产物和血清蛋白浸润导致异种移植生物材料变性的病理生理学和预防
- 批准号:
10679910 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Multifunctional Intelligent Hierarchical Fibrous Biomaterials Integrated with Multimodal Biosensing and Feedback-Based Interventions for Healing Infected Chronic Wounds
多功能智能分层纤维生物材料与多模式生物传感和基于反馈的干预措施相结合,用于治愈感染的慢性伤口
- 批准号:
10861531 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery
小儿心脏手术中植入生物材料加速钙化和结构退化的机制
- 批准号:
10655959 - 财政年份:2023
- 资助金额:
-- - 项目类别: